SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    J. A. Haque, M. G. McDonald, J. D. Kulman, A. E. Rettie, A cellular system for quantitation of vitamin K cycle activity: structure-activity effects on vitamin K antagonism by warfarin metabolites, Blood, 2014, 123, 4, 582

    CrossRef

  2. 2
    Benjamin Matagrin, Adrien Montagut-Romans, Marlene Damin, Marc Lemaire, Florence Popowycz, Etienne Benoit, Virginie Lattard, Identification of VKORC1 genotype leading to resistance to tecarfarin, The Journal of Clinical Pharmacology, 2014, 54, 8
  3. 3
    A. Fregin, K. J. Czogalla, J. Gansler, S. Rost, M. Taverna, M. Watzka, C. G. Bevans, C. R. MüLler, J. Oldenburg, A new cell culture-based assay quantifies vitamin K 2,3-epoxide reductase complex subunit 1 function and reveals warfarin resistance phenotypes not shown by the dithiothreitol-driven VKOR assay, Journal of Thrombosis and Haemostasis, 2013, 11, 5
  4. 4
    Carville G. Bevans, Christoph Krettler, Christoph Reinhart, Hélène Tran, Katja Koßmann, Matthias Watzka, Johannes Oldenburg, Determination of the warfarin inhibition constant Ki for vitamin K 2,3-epoxide reductase complex subunit-1 (VKORC1) using an in vitro DTT-driven assay, Biochimica et Biophysica Acta (BBA) - General Subjects, 2013, 1830, 8, 4202

    CrossRef

  5. 5
    J.-K. Tie, D.-Y. Jin, K. Tie, D. W. Stafford, Evaluation of warfarin resistance using transcription activator-like effector nucleases-mediated vitamin K epoxide reductase knockout HEK293 cells, Journal of Thrombosis and Haemostasis, 2013, 11, 8
  6. 6
    K. J. Czogalla, A. Biswas, A.-C. Wendeln, P. Westhofen, C. R. Muller, M. Watzka, J. Oldenburg, Human VKORC1 mutations cause variable degrees of 4-hydroxycoumarin resistance and affect putative warfarin binding interfaces, Blood, 2013, 122, 15, 2743

    CrossRef

  7. 7
    Benjamin Matagrin, Ahmed Hodroge, Adrien Montagut-Romans, Julie Andru, Isabelle Fourel, Stéphane Besse, Etienne Benoit, Virginie Lattard, New insights into the catalytic mechanism of vitamin K epoxide reductase (VKORC1) – The catalytic properties of the major mutations of rVKORC1 explain the biological cost associated to mutations, FEBS Open Bio, 2013, 3, 144

    CrossRef

  8. 8
    Wade D. Van Horn, Structural and functional insights into human vitamin K epoxide reductase and vitamin K epoxide reductase-like1, Critical Reviews in Biochemistry and Molecular Biology, 2013, 48, 4, 357

    CrossRef